Mother-to-child transmission of toxoplasmosis: Risk estimates for clinical counselling

Lancet

Volumn 353, Issue 9167, 1999, Pages 1829-1833

  Dunn, David ^a   Wallon, Martine ^b   Peyron, Francois ^c   Petersen, Eskild ^a   Peckham, Catherine ^b   Gilbert, Ruth ^c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b CROIX ROUSSE HOSPITAL   (France)

^c STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT;

ARTICLE; CONGENITAL TOXOPLASMOSIS; COUNSELING; FEMALE; GESTATIONAL AGE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MOTHER FETUS RELATIONSHIP; NONHUMAN; PARASITE TRANSMISSION; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SEROCONVERSION; TOXOPLASMA GONDII; VERTICAL TRANSMISSION;

EID: 0033614660     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)08220-8     Document Type: Article

References (26)

1. Remington JS, McLeod R, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant, 4th edn. Philadelphia: WB Saunders, 1995: 140-267.
2. Raeber PA, Biederman K, Just M, Zuber P. Die Pravention der kongenitalen toxoplasmose in Europa. Schweiz Med Wochenschr 1995; 125 (supp!65): 96S-102S.
3. Jeannel D, Costagliola D, Niel G, Hubert B, Danis M. What is known about the prevention of congenital toxoplasmosis? Lancet 1990; 336: 359-61.
4. Hall SM. Congenital toxoplasmosis. BMJ 1992; 305:291-97.
5. Desmonts G, Couvreur J. Toxoplasmose congénitale. Etude prospective d l'issue de la grosesse chez 542 femmes atteintes de toxoplasmose acquise en cours de gestation. Ann Pediatr 1 984; 31: 805-09.
6. Pratlong F, Boulot P, Issert E, et al. Fetal diagnosis of toxoplasmosis in 190 women infected during pregnancy. Prenat Diagn 1994; 14: 191-98.
7. Hohlfeld P, Daffos F, Costa J-M, Thulliez P, Forestier F, Vidaud M. Prenatal diagnosis of congenital toxoplasmosis with a polymerase chain reaction test on amniotic fluid. N EnglJ Med 1994; 331:695-99.
8. Thulliez P. Screening programme for congenital toxoplasmosis in France. ScandJ Infect Dis Suppl 1992; 84: 43J-5.
9. Pons JC, Sigrand C, Grangeot-Keros L, Frydman R, Thulliez P. Congenital toxoplasmosis: mother-to-child transmission of prepregnancy infection. Presse Med 1995; 24: 179-82.
10. Cozon G, Roure C, Lizard G, et al. An improved assay for the detection of toxoplasma gondii antibodies in human serum by flow cytometry. Cytometry 1993; 14: 569-75.
11. Couvreur J Desmonts G, Tournier G. Etude d'une série homogene de 21 0 cas de toxoplasmose congénitale chez des nourrisons agés 0 a1 mois dépistés de facon prospective. Semin Hop Paris 1 985; 61 : 3015-19.
12. Peyron F, Walton M, Bemardoux C. Long-term follow-up of patients with congenital ocular toxoplasmosis. N Engl J Med 1995; 334: 993-94.
13. Bacchetti P. Estimating the incubation period of AIDS by comparing population and diagnosis patterns. J Am Stat Assoc 1990; 85: 1002-08.
14. De Gruttola V, Lagakos SW. Analysis of double-censored survival data, with application to AIDS. Biometrics 1989; 45: 1-11.
15. Numerical Algorithms Group. The NAG Fortran Library Manual (Mark 14). Oxford: Numerical Algorithms Group, 1990.
16. HinkleyDV. Bootstrap methods. J Royal Stat SocB 1991; 10: 1753-73.
17. Daffos F, Forestier F, Capella-Pavlovsky M, et al. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N EnglJ Med 1988; 318: 271-75.
18. Berrebi A, Kobuch WE, Bessieres MH, et al. Termination of pregnancy for maternal toxoplasmosis. Lancet 1994; 344: 36-39.
19. McAuleyJ, Boyer KM, Patel D, et al. Early and longitudinal evaluation of treated infants and children of untreated historical patients with congenital toxoplasmosis: The Chicago Collaborative Treatment Trial. Clin Infect Dis 1994; 18: 38-72.
20. Hohlfeld P, Daffos F, Thulliez P, et al. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. JPeds 1989; 115:765-69.
21. Desmonts G. Toxoplasmose acquise de la femme enceinte: estimation du risque de transmission du parasite et de toxoplasmose congénitale. LyonMed 1982;248:115-23.
22. Ades AE. Evaluating the sensitivity and predictive value of tests of recent infection: toxoplasmosis in pregnancy. Epidemiol Infect 1991 ; 107:527-35.
23. Roizen N, Swisher CN, Stein MA, et al. Neurologic and developmental outcome in treated congenital toxoplasmosis. Pediatrics 1995; 95: 11-20.
24. Guerina NG, Hsu HW, Meissner HC, et al. Neonatal sérologie screening and early treatment for congenital Toxoplasma gondii infection. N Engl J Med 1994; 330: 1858-63.
25. Koppe JG, Rothova A. Congenital toxoplasmosis: a long-term followup of 20 years. Int Ophthalmol 1989; 13:387-90.
26. Gilbert RE, Stanford MR, Jackson H, Holliman RE, Sanders MD. Incidence of acute symptomatic toxoplasma retinochoroiditis in south London according to country of birth. BMJ 1995; 310: 103-7J0.